Two Major COVID Clinical Trials Were Paused Over Safety Concerns — Which Is Exactly How Trials Should Work

Trials for Eli Lilly’s antibody treatment and Johnson & Johnson’s COVID-19 vaccine were both paused this week.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BuzzFeed /  🏆 730. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Korea's Celltrion gets approval for Phase 3 trials of COVID-19 antibody drugSouth Korean drugmaker Celltrion Inc said on Monday it has received regulatory approval for Phase 3 clinical trials of an experimental COVID-19 treatment.
Read more »

Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick SubjectThe company says an independent committee is reviewing the subject’s illness, and it will review the medical information before deciding whether to restart the studies
Read more »

Johnson & Johnson pauses clinical trials for a Covid vaccine over patient illnessThe trial was paused after an “unexplained” illness in one of its participants and in compliance with regulatory standards, the company said.
Read more »

Johnson & Johnson pauses clinical trials for a Covid-19 vaccine over participant's illnessJohnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, just weeks after it announced that trials were in their final stage.
Read more »

Johnson & Johnson Halt All Covid-19 Vaccine Trials Over ‘Unexplained Illness’The pause includes late-stage stage trials for the group’s single dose Covid-19 vaccine.
Read more »

Johnson & Johnson pauses clinical trials for a Covid-19 vaccine over participant's illnessThe trial was paused in compliance with regulatory standards after an 'unexplained' illness in one of its participants, the company said.
Read more »